Currently out of the existing stock ratings of David Larsen, 206 are a BUY (81.1%), 46 are a HOLD (18.11%), 2 are a SELL (0.79%).

David Larsen

Work Performance Price Targets & Ratings Chart

Analyst David Larsen, currently employed at BTIG, carries an average stock price target met ratio of 42.31% that have a potential upside of 24.97% achieved within 314 days.

David Larsen’s has documented 494 price targets and ratings displayed on 51 stocks. The coverage is on Healthcare, Industrials, Technology, Consumer Defensive, Basic Materials, Consumer Cyclical sectors.

Most recent stock forecast was given on BTSG, BrightSpring Health Services, Common Stock at 19-Mar-2026.

Wall Street Analyst David Larsen

Analyst best performing recommendations are on ONEM (1LIFE HEALTHCARE).
The best stock recommendation documented was for DPLO (DIPLOMAT PHARMACY) at 2/25/2019. The price target of $6 was fulfilled within 1 day with a profit of $0.16 (2.74%) receiving and performance score of 27.4.

Average potential price target upside

ACCD Accolade  CPSI Computer Programs and Systems CVS CVS Health Corp CYRX Cryoport DPLO Diplomat Pharmacy EVH Evolent Health HSIC Henry Schein INOV Inovalon Holdings LFMD LifeMD MCK McKesson MDRX Allscripts Healthcare Solutions OMCL Omnicell TDOC Teladoc VCRA Vocera Communications WBA Walgreens Boots Alliance ABC AmerisourceBergen ATHN athenahealth BBLN Babylon Holdings Ltd CAH Cardinal Health CERN Cerner Corp HCAT Health Catalyst NXGN Nextgen Healthcare ONEM 1Life Healthcare SGFY Signify Health SHCR Sharecare FIT Fitbit PRVA Privia Health Group DCGO DocGo IQV IQVIA Holdings CCSI Consensus Cloud Solutions HQY HealthEquity PGNY Progyny SLP Simulations Plus VEEV Veeva Systems ASTH Astrana Health BTSG BrightSpring Health Services, Common Stock PIII P3 Health Partners DOCS Doximity HIMS Hims Hers Health DH Definitive Healthcare Corp PDCO Patterson Companies PINC Premier TOI Oncology Institute LFST Lifestance Health Group BB BlackBerry Ltd CE Celanese CV INO Inovio Pharmaceuticals PI Impinj SHC Sotera Health Co VC Visteon Corp

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jan-2025

$7.03

1 years 2 months 25 days ago
(09-Jan-2025)

5/10 (50%)

$0.17 (2.48%)

112

Hold Since 09-Jan-2025

$16

1 years 2 months 25 days ago
(09-Jan-2025)

2/3 (66.67%)

$1.01 (6.74%)

79

Hold Since 08-Jan-2025

$5.75

1 years 2 months 26 days ago
(08-Jan-2025)

3/12 (25%)

$1.71 (42.33%)

51

Buy Since 15-Jan-2021

$7.5

$0.48 (6.84%)

$7.5

1 years 2 months 26 days ago
(08-Jan-2025)

6/20 (30%)

$0.64 (9.33%)

75

Hold Since 30-Apr-2022

$5

$-2.02 (-28.77%)

$6

1 years 3 months 17 days ago
(17-Dec-2024)

10/17 (58.82%)

$1.6 (47.06%)

41

Show more analysts

Please expand the browser size to see the chart

Which stock is David Larsen is most bullish on?

Potential upside of $167.41 has been obtained for VEEV (VEEVA SYSTEMS)

Which stock is David Larsen is most reserved on?

Potential downside of -$0 has been obtained for SLP (SIMULATIONS PLUS)

What Year was the first public recommendation made by David Larsen?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?